Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calender
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calender
    • Contact
  • Molecular Med Tri-Conference
 
  • University Of Cincinnati Researchers Develop Device For Diagnostics Via Smartphone

    Diagnostics World News | Engineers at the University of Cincinnati have developed a portable device that brings the capabilities of a diagnostics lab to the smartphone.

    Mar 13, 2020
  • Patient-Centric Approaches to Managing Digital Health Data: Updates from the Molecular Medicine Tri-Conference

    Diagnostics World News | The rapid emergence of electronic health record systems, genetic sequencing services, wearables and other digital health tools in recent years has generated more patient data than ever.

    Mar 12, 2020
  • Leveraging Artificial Intelligence and Machine Learning for Precise, Predictive Medicine: Updates from the Molecular Medicine Tri-Conference

    Diagnostics World News | Although artificial intelligence has generated plenty of buzz in biomedical research, thought leaders at the Molecular Medicine Tri-Conference in San Francisco last week showed that it’s more than just a flashy catchphrase.

    Mar 10, 2020
  • Human Longevity Inc. Changing Healthcare ‘One Patient At A Time’

    Diagnostics World News | Human Longevity Inc. launched six years ago with the goal of building a million-genome database replete with phenotypic and clinical data but is now laser focused on helping its clients live to be 100.

    Mar 6, 2020
  • Together, Doctors And AI Can Process “Helluvabytes” Of Data

    Diagnostics World News | Data is the most valuable resource on the market today, and there’s a lot of it. When it comes to processing health data, the solution may be neural networks. Not AI to replace doctors, says Eric Topol, but AI to empower doctors.

    Mar 5, 2020
  • Co-Diagnostics Presents Rapid Diagnostic Test For Coronavirus In San Francisco

    Diagnostics World News | Co-Diagnostics presented their new rapid diagnostic test for COVID-19 yesterday at the Molecular Medicine TriConference in San Francisco. The Salt Lake City, Utah, diagnostics company is among the many companies working on a rapid diagnostic test for COVID-19.

    Mar 4, 2020
  • Thermo Fisher Scientific To Acquire QIAGEN

    Diagnostics World News | QIAGEN has been acquired by Thermo Fisher Scientific in a deal valued at $11.5 billion, which includes the assumption of approximately $1.4 billion of net debt.

    Mar 3, 2020
  • New Autoinflammatory Disease Discovered

    Diagnostics World News | An international group of scientists has discovered a previously unknown autoinflammatory disease and identified its underlying biological origin.

    Mar 3, 2020
  • Thermo Fisher Scientific, NeuMoDx Molecular, Proscia, And More: News From February 2020

    Diagnostics World News | February featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Thermo Fisher Scientific, NeuMoDx Molecular, Proscia, and more.

    Feb 27, 2020
  • NIH Launches $1M Challenge For Handheld Diagnostics

    Diagnostics World News | The National Institutes of Health today launched a $1 million Technology Accelerator Challenge to spur the design and development of non-invasive, handheld, digital technologies to detect, diagnose, and guide therapies for diseases with high global and public health impact. The challenge is focused on sickle cell disease, malaria, and anemia

    Feb 26, 2020
  • Credo Diagnostics Biomedical Finalizing Rapid Point-Of-Care Molecular Test For Coronavirus Detection

    Diagnostics World News Brief | Credo Diagnostics Biomedical announced they are now finalizing a rapid point-of-care molecular test to detect the novel coronavirus in 20 minutes.

    Feb 26, 2020
  • The Value Of Imaging Data As The Missing Essential Component Of Real World Data

    Diagnostics World News| Radiology is increasingly the key to synthesizing real world evidence with sufficient quality to shape drug performance. As a diagnostic toolset, imaging is one of the oldest and most widely used and clearly interpreted methods for measurement of outcomes. It is regularly used to measure disease progression and to determine the effectiveness of medical interventions. Imaging is also a common mechanism for early identification of disease that can be automated or extended through artificial intelligence (AI).

    Feb 20, 2020
  • Follow the Money: Big Investments in CRISPR Diagnostics, Sepsis Diagnostics

    Diagnostics World News | Some big investments are driving CRISPR-based diagnostics, cell therapies, sepsis diagnostics and more this year.

    Feb 19, 2020
  • CRISPR's Future For Point-Of-Care Diagnostics

    Diagnostics World News | CRISPR applications are exploding, and Can Dincer, with the Freiburg Center for Interactive Materials and Bioinspired Technologies (FIT) and Department of Microsystems Engineering (IMTEK) at the University of Freiburg in Germany, sees uniquely powerful applications for point-of-care diagnostics.

    Feb 18, 2020
  • New Disease Detection Technique: Magnetically Levitating Plasmas

    Diagnostics World News | The same technology that propels the world’s fastest electric train at speeds up to 267 miles per hour is now being used for the first time to levitate proteins in plasma for diagnostic purposes—and tease out differences between healthy and diseased plasma donors.

    Feb 14, 2020
  • Setting Standards For Measuring Circulating Tumor DNA

    Diagnostics World News | Angela Pia Sanzone, Blood Biomarkers Group Leader, Advanced Therapies Division, National Institute for Biological Standards and Control (NIBSC), UK, is working with the World Health Organization on international reference standards for ctDNA that will enable harmonized reporting in diagnostics and patient monitoring.

    Feb 11, 2020
  • Predictive Immune Modeling: Why Immune Profiling Is a Powerful Tool for Understanding and Treating Disease

    Diagnostics World News Contributed Commentary | In order to achieve the goal of truly tailoring therapy regimens to patient’s molecular profiles, it’s imperative that we overcome challenges and move into the next era of biomarker and diagnostic development.

    Feb 7, 2020
  • Diagnostic Community Responds To Coronavirus Outbreak

    Diagnostics World News Brief | The diagnostic community has been quick to respond to the recent outbreak of coronavirus that originated in Wuhan, China. Companies have announced commitments to combating the virus, either through funding or technology application.

    Feb 6, 2020
  • A Regulatory View of Personalized Therapeutics

    Diagnostics World News | The FDA’s Director of the Center for Biologics Evaluation and Research discusses the obstacles in developing gene therapies, emerging developments in the field, and the regulatory landscape surrounding personalized therapeutics.

    Feb 5, 2020
  • Containing The Coronavirus

    Diagnostics World News Contributed Commentary | With the outbreak and fast spread of Novel Coronavirus, including at least 106 deaths, as of Tuesday morning, the question on everyone’s mind is “Can the 2019-nCoV virus be contained?”

    Feb 4, 2020
  • «
  • 41 (current)
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy